What are you looking for?

Conferences

Clinical Operations in Oncology Trials Europe 2018

For its 5th edition, the Clinical Operations in Oncology Trials Europe Conference took place in Munich. Participants were invited to attend a practical workshop on strengthening collaboration through vendor management; a global project leader discussing how and why patients should be involved in protocol design; and a technology spotlight session.

Past

Schedule

14 November

14:00 to 17:00

A Nussbaum

Methods for Tobacco Harm Reduction: Introducing the Scientific Assessment Program of PMI Science

A. Nussbaum_Methods for Tobacco Harm Reduction Introducing the Scientific Assessment Program of PMI Science
4311 KB
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

Our RRPs

Reduced-risk products ("RRPs") is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. We have a range of RRPs in various stages of development, scientific assessment and commercialization. Because our RRPs do not burn tobacco, they produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.